Basil Sharrack
Glossop Road
Sheffield, ENG, United Kingdom
Sheffield, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 03, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026
The future of clinical trials? Monitoring mobility as an outcome measure in Parkinson's disease: The mobilise-D study.
Journal: Journal of Parkinson's disease
Published: December 26, 2025
Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT).
Journal: Bone marrow transplantation
Published: December 10, 2025
Fatigue prevalence, interactions with associated symptoms and longitudinal changes in those with multiple sclerosis: Insights from the TONiC study.
Journal: Journal of the neurological sciences
Published: December 01, 2025
Employment status in people with multiple sclerosis: Profile, dynamic changes and determinants over time.
Journal: Multiple sclerosis and related disorders
Published: November 04, 2025
The construct validity of real-world digital mobility outcomes in people with COPD.
Journal: ERJ open research
Published: July 24, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 07, 2025
BEAM/ATG or cyclophosphamide/ATG as conditioning regimen in autologous haemopoietic stem cell transplantation for multiple sclerosis: a retrospective analysis of the EBMT autoimmune diseases working party.
Journal: Bone marrow transplantation
Published: May 19, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 14, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 23, 2025
Recruitment of the multiple sclerosis cohort within the European Mobilise-D clinical validation study-lessons learnt, baseline demographics and clinical characteristics.
Journal: Trials
Published: February 24, 2025
Last Updated: 09/26/2026